Research Papers

25 of 400 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Potential use of high-resolution melting analyses for SARS-CoV-2 genomic surveillance.
de Souza Andrade A; Freitas EF; de Castro Barbosa E; Guimarães NR; de Melo Iani FC; da Costa AVB; Bernardes AFL; Adelino TER; Ataide ACZ; Gregianini TS; Nunes JD; Stringari LL; Riediger IN; Fernandes SB; de Jesus R; Fonseca V; Caldas S.
J Virol Methods (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
β-Propiolactone (BPL)-inactivation of SARS-Co-V-2: In vitro validation with focus on saliva from COVID-19 patients for …
Pilchová V; Prajeeth CK; Jendrny P; Twele F; Meller S; Pink I; Fathi A; Addo MM; Volk HA; Osterhaus A; von Köckritz-Blickwede M; Schulz C.
J Virol Methods (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Comparison of a rapid fluorescence immunochromatographic test with an enzyme-linked immunosorbent assay for measurement…
Filippatos F; Tatsi EB; Papagiannopoulos C; Syriopoulou V; Michos A.
J Virol Methods (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Evaluation of a novel anterior nasal swab for the detection of SARS-CoV-2.
Crowe A; Lorenzo YP; Jardine D; Visvanathan K.
J Virol Methods (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
'CoviSwift<sup>TM'</sup>: A point-of-care RT-PCR device for SARS-CoV-2 and its variant detection.
Dakhave M; Gadekar S; Malekar A; Wankhede G.
J Virol Methods (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Practical use of tobravirus-based vector to produce SARS-CoV-2 antigens in plants.
Andrade IA; Franca LV; Kauffmann CM; Maeda MHK; Koyama LHH; Hamann PRV; Lopes-Luz L; Fogaça MBT; Camargo BR; Ribeiro BM; Bührer-Sékula S; Nagata T.
J Virol Methods (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Development of a validated molecular analytical method to determine the viral safety of F(AB´)<sub>2</sub> products: A …
Sánchez-Pacheco UA; Bahena-Mondragón BM; Hernández-Piedras FR; Soria-Osorio R; Meneses-Acosta A.
J Virol Methods (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Impact of G29179T mutation on two commercial PCR assays for SARS-CoV-2 detection.
Kami W; Kinjo T; Hashioka H; Arakaki W; Uechi K; Takahashi A; Oki H; Tanaka K; Motooka D; Nakamura S; Nakamatsu M; Maeda S; Yamamoto K; Fujita J.
J Virol Methods (Unknown)
Published: 2023
2/6 Transparent
Evaluation of extraction and enrichment methods for recovery of respiratory RNA viruses in a metagenomics approach.
Ogunbayo AE; Sabiu S; Nyaga MM.
J Virol Methods (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Combined nasal- and oropharyngeal self-swab provides equivalent performance compared to professionally collected oropha…
Hørlyck S; Nielsen SH; Gress T; Schneider U; Martel CJ; Steenhard N; Gredal NT; Mortensen S; Cohen AS.
J Virol Methods (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
SpikeSeq: A rapid, cost efficient and simple method to identify SARS-CoV-2 variants of concern by Sanger sequencing par…
Jørgensen TS; Pedersen MS; Blin K; Kuntke F; Salling HK; Marvig RL; Michaelsen TY; Albertsen M; Larsen H.
J Virol Methods (Unknown)
Published: 2022
5/6 Transparent
Data Code Funding Declared
Assessment of two volumetrically different concentration approaches to improve sensitivities for SARS-CoV-2 detection d…
McMinn BR; Korajkic A; Pemberton AC; Kelleher J; Ahmed W; Villegas EN; Oshima K.
J Virol Methods (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Evaluation of a simple ultrafiltration method for concentration of infective canine parvovirus and feline coronavirus f…
Khan MAA; Schoene K; Cashman J; Abd El Wahed A; Truyen U.
J Virol Methods (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Evaluation of the impact of pre-analytical conditions on sample stability for the detection of SARS-CoV-2 RNA.
Mosscrop L; Watber P; Elliot P; Cooke G; Barclay W; Freemont PS; Rosadas C; Taylor GP.
J Virol Methods (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Development of a simple genotyping method based on indel mutations to rapidly screen SARS-CoV-2 circulating variants: D…
Ayadi W; Taktak A; Gargouri S; Smaoui F; Chtourou A; Skouri-Gargouri H; Derbel R; Sassi AH; Gargouri A; Hammami A; Karray-Hakim H; Mokdad-Gargouri R; Fki-Berrajah L.
J Virol Methods (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Comparison of commercial SARS-CoV-2 surrogate neutralization assays with a full virus endpoint dilution neutralization …
Adams O; Andrée M; Hermsen D; Lübke N; Timm J; Schaal H; Müller L.
J Virol Methods (Unknown)
Published: 2022
2/6 Transparent
Cell-based reporter assays for measurements of antibody-mediated cellular cytotoxicity and phagocytosis against SARS-Co…
Hong Y; Guo H; Wei M; Zhang Y; Fang M; Cheng T; Li Z; Ge S; Yao X; Yuan Q; Xia N.
J Virol Methods (Unknown)
Published: 2022
4/6 Transparent
Data Funding Declared
Fast detection of SARS-CoV-2 variants including Omicron using one-step RT-PCR and Sanger sequencing.
Bloemen M; Rector A; Swinnen J; Ranst MV; Maes P; Vanmechelen B; Wollants E.
J Virol Methods (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
SARS-CoV-2 spike antigen quantification by targeted mass spectrometry of a virus-based vaccine.
Rosen O; Jayson A; Dor E; Epstein E; Makovitzki A; Cherry L; Lupu E; Monash A; Borni S; Baruchi T; Laskar O; Shmaya S; Rosenfeld R; Levy Y; Schuster O; Feldberg L.
J Virol Methods (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Effect of not vortexing nasopharyngeal and throat swabs on SARS-CoV-2 nucleic acid detection: A pilot study.
Kanji JN; Pabbaraju K; Wong A; Beitku C; Deo A; Kailey S; Ma R; Tipples G; Zelyas N.
J Virol Methods (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
A robust, cost-effective and widely applicable whole-genome sequencing protocol for capripoxviruses.
Mathijs E; Haegeman A; De Clercq K; Van Borm S; Vandenbussche F.
J Virol Methods (Unknown)
Published: 2022
4/6 Transparent
Data Funding Declared
SARS-CoV-2 multiplex RT-PCR to detect variants of concern (VOCs) in Malaysia, between January to May 2021.
Fu JYL; Chong YM; Sam IC; Chan YF.
J Virol Methods (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Time series analysis and predicting COVID-19 affected patients by ARIMA model using machine learning.
Chyon FA; Suman MNH; Fahim MRI; Ahmmed MS.
J Virol Methods (Unknown)
Published: 2021
1/6 Transparent
Use of Sanger protocols to identify variants of concern, key mutations and track evolution of SARS-CoV-2.
Cabral GB; Ahagon CM; de Souza Guimarães PM; Silva Lopez-Lopes GI; Hussein IM; Cilli A; de Jesus Alves I; Coelho Bombonatte AG; do Carmo Sampaio Tavares Timenetsky M; da Silva Santos JH; de Oliveira Santos KC; Dos Santos FCP; de Macedo Brígido LF.
J Virol Methods (Unknown)
Published: 2021
3/6 Transparent
Registered Funding Declared
Evaluation of two RT-PCR techniques for SARS-CoV-2 RNA detection in serum for microbiological diagnosis.
Martín Ramírez A; Zurita Cruz ND; Gutiérrez-Cobos A; Rodríguez Serrano DA; González Álvaro I; Roy Vallejo E; Gómez de Frutos S; Fontán García-Rodrigo L; Cardeñoso Domingo L.
J Virol Methods (Unknown)
Published: 2021
3/6 Transparent
Funding Declared